Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48975#.VJdymcCAM4 Author(s) Karin R. Purshouse Affiliation(s) University of Edinburgh, Old College, Edinburgh, UK . ABSTRACT Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development. KEYWORDS Oncology , Small Cell Lung Cancer , Targeted Therapy , Drug Development ...
Scientific Research Publishing